オープン アクセスを義務付けられた論文 - Omid Farokhzad詳細
一般には非公開: 15 件
Nanoparticle delivery of cancer drugs
AZ Wang, R Langer, OC Farokhzad
Annual review of medicine 63 (1), 185-198, 2012
委任: US National Institutes of Health
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile
J Hrkach, D Von Hoff, MM Ali, E Andrianova, J Auer, T Campbell, ...
Science translational medicine 4 (128), 128ra39-128ra39, 2012
委任: US National Institutes of Health
Challenges in DNA delivery and recent advances in multifunctional polymeric DNA delivery systems
B Shi, M Zheng, W Tao, R Chung, D Jin, D Ghaffari, OC Farokhzad
Biomacromolecules 18 (8), 2231-2246, 2017
委任: US National Institutes of Health, National Health and Medical Research …
Hydrophobic cysteine poly (disulfide)‐based redox‐hypersensitive nanoparticle platform for cancer theranostics
J Wu, L Zhao, X Xu, N Bertrand, WII Choi, B Yameen, J Shi, V Shah, ...
Angewandte Chemie 127 (32), 9350-9355, 2015
委任: US National Institutes of Health, Canadian Institutes of Health Research
Nanotechnology-based strategies for siRNA brain delivery for disease therapy
M Zheng, W Tao, Y Zou, OC Farokhzad, B Shi
Trends in biotechnology 36 (5), 562-575, 2018
委任: National Health and Medical Research Council, Australia, National Natural …
Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy
Y Liu, Y Zou, C Feng, A Lee, J Yin, R Chung, JB Park, H Rizos, W Tao, ...
Nano letters 20 (3), 1637-1646, 2020
委任: National Health and Medical Research Council, Australia, National Natural …
Oral insulin delivery platforms: strategies to address the biological barriers
Y Xiao, Z Tang, J Wang, C Liu, N Kong, OC Farokhzad, W Tao
Angewandte Chemie International Edition 59 (45), 19787-19795, 2020
委任: American Heart Association
Nanotechnology for drug delivery: the perfect partnership
OC Farokhzad
Expert opinion on drug delivery 5 (9), 927-929, 2008
委任: US National Institutes of Health
Theranostic nanomedicine in the NIR-II window: classification, fabrication, and biomedical applications
W Tao, OC Farokhzad
Chemical Reviews 122 (6), 5405-5407, 2022
委任: American Heart Association
Polymer-and protein-based nanotechnologies for cancer theranostics
X Zhu, ELB Anquillare, OC Farokhzad, J Shi
Cancer theranostics, 419-436, 2014
委任: US National Institutes of Health
Nanostructure engineering by simple tuning of lipid combinations
PE Saw, X Xu, M Zhang, S Cao, OC Farokhzad, J Wu
Angewandte Chemie International Edition 59 (15), 6249-6252, 2020
委任: National Natural Science Foundation of China
Role of electrostatic interactions in protein loading in PLGA-PEG nanoparticles
S Chopra, JM Lim, R Karnik, O Farokhzad
2014 40th Annual Northeast Bioengineering Conference (Nebec), 1-2, 2014
委任: US National Institutes of Health
Aptamer conjugates: emerging delivery platforms for targeted cancer therapy
Z Xiao, J Frieder, BA Teply, OC Farokhzad
Drug Delivery in Oncology: From Basic Research to Cancer Therapy, 1263-1281, 2011
委任: US National Institutes of Health
Stimuli-responsive nanotheranostics
B Yameen, J Wu, C Vilos, A Whyte, D Werstler, L Pollit, OC Farokhzad
Nanotheranostics for Personalized Medicine, 267-296, 2016
委任: US National Institutes of Health
Plattformen für die orale Insulinabgabe: Strategien zur Beseitigung der biologischen Barrieren
Y Xiao, Z Tang, J Wang, C Liu, N Kong, OC Farokhzad, W Tao
Angewandte Chemie 132 (45), 19955-19964, 2020
委任: American Heart Association
一般公開: 146 件
Nanocarriers as an emerging platform for cancer therapy
D Peer, JM Karp, S Hong, OC Farokhzad, R Margalit, R Langer
Nano-enabled medical applications, 61-91, 2020
委任: US National Institutes of Health
Cancer nanomedicine: progress, challenges and opportunities
J Shi, PW Kantoff, R Wooster, OC Farokhzad
Nature reviews cancer 17 (1), 20-37, 2017
委任: US Department of Defense, US National Institutes of Health
Factors affecting the clearance and biodistribution of polymeric nanoparticles
F Alexis, E Pridgen, LK Molnar, OC Farokhzad
Molecular pharmaceutics 5 (4), 505-515, 2008
委任: US National Institutes of Health
Nanoparticles in medicine: therapeutic applications and developments
L Zhang, FX Gu, JM Chan, AZ Wang, RS Langer, OC Farokhzad
Clinical pharmacology & therapeutics 83 (5), 761-769, 2008
委任: US National Institutes of Health
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology
N Bertrand, J Wu, X Xu, N Kamaly, OC Farokhzad
Advanced drug delivery reviews 66, 2-25, 2014
委任: US National Institutes of Health, Canadian Institutes of Health Research
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます